13537-305 : Esika Topical Lotion


NDC: 13537-305
Labeler: Ventura Corporation (San Juan, P.r)
Product Type: Human OTC Drug
Drug Name: Esika Hydro-nutrative Foundation Spf 13
Dosage Form: Topical Lotion
Application #: part352
Rev. Date: 


NDC Package Codes:

  • 13537-305-02: 1 BOTTLE IN 1 BOX (13537‑305‑02) > 30 ML IN 1 BOTTLE (13537‑305‑01)

Active Ingredients:

  • Octinoxate
  • Oxybenzone

Dosage Strength:

  • .05 mg/mL
  • .02 mg/mL

Related Products:

Based on records with the same trade name.
  • 13537-306 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)
  • 13537-307 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)
  • 13537-308 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)
  • 13537-309 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)
  • 13537-310 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)
  • 13537-311 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)
  • 13537-312 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)
  • 13537-313 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)
  • 13537-314 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)
  • 13537-315 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)
  • 13537-316 Esika Topical Lotion by Ventura Corporation (San Juan, P.r)

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 13537-305 QR Code

< Prev: 13537-304Next: 13537-306 >

Related Discussions:

homosalate oxybenzone
affects on gender, gender bender?...
n a octyl methoxy cinnimate octyl salicylates oxybenzone
I need the suppliers of UV absorbers like oxybenzone,.octyl salicylates, .octyl methoxy cinnimate...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.